(Q50501091)

14 March 2018

title

A detailed examination of the antibody prevalence and characteristics of anti-ESA antibodies. (English)

1 reference

14 March 2018

author name string

Troy E Barger

1

1 reference

14 March 2018

Deborah Wrona

2

1 reference

14 March 2018

Theresa J Goletz

3

1 reference

14 March 2018

Daniel T Mytych

4

1 reference

14 March 2018

language of work or name

English

0 references

publication date

1 October 2012

1 reference

14 March 2018

Nephrology Dialysis Transplantation

published in

1 reference

14 March 2018

volume

27

1 reference

14 March 2018

issue

10

1 reference

14 March 2018

page(s)

3892-3899

1 reference

14 March 2018

Immune responses to therapeutic proteins in humans--clinical significance, assessment and prediction

cites work

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS392

Affinity maturation and class switching

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS392

Pure red cell aplasia induced by erythropoiesis-stimulating agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS392

Eprex-associated pure red cell aplasia and leachates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS392

High-avidity autoantibodies to cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS392

Naturally occurring B-cell autoreactivity: a critical overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS392

A cross-sectional immunosurveillance study of anti-EPO antibody levels in CRF patients receiving epoetin alfa in 5 Ontario Renal Centers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS392

Detection of anti-ESA antibodies in human samples from PRCA and non-PRCA patients: an immunoassay platform comparison.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS392

Circulating autoantibodies to erythropoietin are associated with human immunodeficiency virus type 1-related anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS392

The development and validation of a sensitive, dual-flow cell, SPR-based biosensor immunoassay for the detection, semi-quantitation, and characterization of antibodies to darbepoetin alfa and epoetin alfa in human serum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS392

Development and validation of a cell-based bioassay for the detection of neutralizing antibodies against recombinant human erythropoietin in clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS392

Long-term outcome of individuals with pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant epoetin: a follow-up report from the Research on Adverse Drug Events and Reports (RADAR) Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS392

The increased incidence of pure red cell aplasia with an Eprex formulation in uncoated rubber stopper syringes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS392

Importance of biologic follow-ons: experience with EPO.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS392

Epoetin-associated pure red cell aplasia: past, present, and future considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS392

Anti-erythropoietin antibodies and pure red cell aplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS392

Pure red cell aplasia due to follow-on epoetin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS392

Natural IgM antibodies: the orphaned molecules in immune surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS392

Implications of the presence of N-glycolylneuraminic acid in recombinant therapeutic glycoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS392

Sugar profiling proves that human serum erythropoietin differs from recombinant human erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS392

Development of a maturing T-cell-mediated immune response in patients with idiopathic Parkinson's disease receiving r-metHuGDNF via continuous intraputaminal infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS392

Detection and characterization of antibodies against recombinant human erythropoietin by RIPA, ELISA and neutralization assay in patients with renal anemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS392

Assays for detecting and diagnosing antibody-mediated pure red cell aplasia (PRCA): an assessment of available procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS392

21 January 2018

Identifiers

DOI

10.1093/NDT/GFS392

1 reference

14 March 2018

1 reference

14 March 2018